Loading...
XASX
NAN
Market cap841mUSD
Dec 05, Last price  
4.17AUD
1D
0.72%
1Q
3.73%
Jan 2017
34.08%
IPO
441.56%
Name

Nanosonics Ltd

Chart & Performance

D1W1MN
XASX:NAN chart
P/E
61.28
P/S
6.37
EPS
0.07
Div Yield, %
—
Shrs. gr., 5y
0.34%
Rev. gr., 5y
14.89%
Revenues
199m
+15.95%
8,4240309,000763,0002,247,00012,301,00014,899,00021,492,00022,214,00042,796,00067,507,00060,698,00084,324,00099,382,000101,834,000119,728,000167,515,000171,561,000198,929,000
Net income
21m
+59.39%
-5,703,524-7,147,000-8,754,000-8,172,000-11,214,000-4,679,000-5,768,000-2,605,000-5,460,000122,00026,158,0005,751,00013,602,00010,137,0008,578,0003,742,00019,883,00012,972,00020,676,000
CFO
44m
+93.06%
-4,586,396-7,135,000-9,136,000-7,762,000-9,001,000-5,029,000-4,506,000-2,594,000-2,421,0003,224,00016,388,0009,009,0004,826,00022,764,0007,315,0006,695,00023,314,00022,782,00043,983,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
URL
https://www.nanosonics.com.au/
IPO date
May 17, 2007
Employees
482
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT